ConcertAI introduces predictive and generative AI solutions powered by multi-modal real-world data, key partnerships, CARA AI, and more at the 2024 ASCO Annual Meeting

Solutions enable both research and clinical teams with precision oncology, accelerating clinical trials, increasing patient access, and driving improved patient outcomes CAMBRIDGE, Mass., May 31, 2024 /PRNewswire/ — ConcertAI, a leader in oncology...

ConcertAI Highlights 2024 Partnerships, Strategy, Business Results, and AI Roadmap at 42nd Annual J.P. Morgan Healthcare Conference

Introduced CARA™, the predictive and generative AI Platform powered by multi-modal Real-World Data, enabling precision oncology, accelerating clinical trials, increasing patient access, driving improved patient outcomes. CAMBRIDGE, Mass., Jan. 11, 2024 /PRNewswire/...

ConcertAI and NeoGenomics Announce Collaboration to Advance Population-Scale, Definitive Hematological Research & Generative AI Solutions at 2024 JP Morgan Conference

CAMBRIDGE, Mass., Jan. 8, 2024 /PRNewswire/ — ConcertAI, LLC, a leading oncology real-world evidence data and AI technology company, and NeoGenomics, Inc., a leading oncology testing services company, today announced a broad...